ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab.

Cosme Sandoval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.